Guggul (Expanded) for Acne Treatment

Research suggests that guggul and guggul-derived formulations may help reduce acne lesions, with the most direct clinical evidence coming from two randomized controlled trials. A small 1994 RCT found gugulipid performed comparably to tetracycline for nodulocystic acne over three months, with potentially fewer relapses, while a 2025 double-blind, placebo-controlled trial of 100 participants found a guggul-containing herbal capsule significantly outperformed placebo in reducing both inflammatory and non-inflammatory lesions and improving quality of life measures. Supportive reviews of the broader guggulipid literature point to plausible anti-inflammatory and antibacterial mechanisms that could explain these effects. However, the evidence base remains limited — the 1994 trial was very small, the 2025 trial tested a multi-ingredient formulation rather than guggul alone, and the supporting reviews are narrative rather than systematic, making it difficult to draw firm conclusions about guggul's independent contribution or long-term efficacy.